Downregulation of microRNA-429 protects cardiomyocytes against hypoxia-induced apoptosis by increasing Notch1 expression

International Journal of Molecular Medicine

Volumn 37, Issue 6, 2016, Pages 1677-1685

  Xu, Han ^a   Jin, Long ^b   Chen, Yan ^a   Li, Junzhi ^a  

^a Department of Emergency ^*  (China)

^b Ninth Hospital of xi'An   (China)

Author keywords

Apoptosis; Cardiomyocytes; MicroRNA 429; Notch1; Sudden cardiac death

Indexed keywords

MICRORNA; MICRORNA 429; NOTCH1 RECEPTOR; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN429 MICRORNA, HUMAN; NOTCH1 PROTEIN, HUMAN; OLIGONUCLEOTIDE;

APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HYPOXIA; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; 3' UNTRANSLATED REGION; ANTAGONISTS AND INHIBITORS; BINDING SITE; CELL HYPOXIA; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR MIMICRY; NUCLEOTIDE SEQUENCE; PATHOLOGY;

3' UNTRANSLATED REGIONS; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CELL HYPOXIA; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MOLECULAR MIMICRY; MYOCYTES, CARDIAC; OLIGONUCLEOTIDES; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION;

EID: 84978818250     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2558     Document Type: Article

References (36)

1. Jianqiang P, Ping Z, Xinmin F, Zhenhua Y, Ming Z and Ying G: Expression of hypoxia-inducible factor 1 alpha ameliorate myocardial ischemia in rat. Biochem Biophys Res Commun 465: 691-695, 2015.
2. Elsässer A, Suzuki K, Lorenz-Meyer S, Bode C and Schaper J: The role of apoptosis in myocardial ischemia: A critical appraisal. Basic Res Cardiol 96: 219-226, 2001.
3. Freude B, Masters TN, Robicsek F, Fokin A, Kostin S, Zimmermann R, Ullmann C, Lorenz-Meyer S and Schaper J: Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol 32: 197-208, 2000.
4. Kloner RA: Does reperfusion injury exist in humans? J Am Coll Cardiol 21: 537-545, 1993.
5. Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
6. Bracken CP, Whitelaw ML and Peet DJ: The hypoxia-inducible factors: Key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 60: 1376-1393, 2003.
7. Choudhuri S: Small noncoding RNAs: Biogenesis, function, and emerging significance in toxicology. J Biochem Mol Toxicol 24: 195-216, 2010.
8. Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF, Ren AJ, Yuan WJ and Lin L: Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 17: 410-423, 2012.
9. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, et al: MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122 (Suppl 11): S124-S131, 2010.
10. Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF and Srivastava D: miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med 208: 549-560, 2011.
11. Li AY, Yang Q and Yang K: miR-133a mediates the hypoxia-induced apoptosis by inhibiting TAGLN2 expression in cardiac myocytes. Mol Cell Biochem 400: 173-181, 2015.
12. Wang X, Li C and Dai Q: Downregulation of microRNA-26b rescued hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes by regulating PTEN. Int J Clin Exp Med 8: 4073-4079, 2015.
13. Tang J, Li L, Huang W, Sui C, Yang Y, Lin X, Hou G, Chen X, Fu J, Yuan S, et al: MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition. Cancer Lett 364: 33-43, 2015.
14. Li J, Du L, Yang Y, Wang C, Liu H, Wang L, Zhang X, Li W, Zheng G and Dong Z: MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett 329: 84-90, 2013.
15. Gao H and Liu C: miR-429 represses cell proliferation and induces apoptosis in HBV-related HCC. Biomed Pharmacother 68: 943-949, 2014.
16. Wang Y, Li M, Zang W, Ma Y, Wang N, Li P, Wang T and Zhao G: MiR-429 upregulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol (Dordr) 36: 385-394, 2013.
17. Ye ZB, Ma G, Zhao YH, Xiao Y, Zhan Y, Jing C, Gao K, Liu ZH and Yu SJ: miR-429 inhibits migration and invasion of breast cancer cells in vitro. Int J Oncol 46: 531-538, 2015.
18. Lei W, Liu YE, Zheng Y and Qu L: MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1. Med Sci Monit 21: 383-389, 2015.
19. von Boehmer H: Coming to grips with Notch. J Exp Med 194: F43-F46, 2001.
20. Miele L and Osborne B: Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol 181: 393-409, 1999.
21. Li Y, Hiroi Y and Liao JK: Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction. Trends Cardiovasc Med 20: 228-231, 2010.
22. Del Monte G, Grego-Bessa J, González-Rajal A, Bolós V and De La Pompa JL: Monitoring Notch1 activity in development: Evidence for a feedback regulatory loop. Dev Dyn 236: 2594-2614, 2007.
23. Grego-Bessa J, Luna-Zurita L, del Monte G, Bolós V, Melgar P, Arandilla A, Garratt AN, Zang H, Mukouyama YS, Chen H, et al: Notch signaling is essential for ventricular chamber development. Dev Cell 12: 415-429, 2007.
24. Gude NA, Emmanuel G, Wu W, Cottage CT, Fischer K, Quijada P, Muraski JA, Alvarez R, Rubio M, Schaefer E and Sussman MA: Activation of Notch-mediated protective signaling in the myocardium. Circ Res 102: 1025-1035, 2008.
25. Chiba S: Notch signaling in stem cell systems. Stem Cells 24: 2437-2447, 2006.
26. del Monte G, Casanova JC, Guadix JA, MacGrogan D, Burch JB, Pérez-Pomares JM and de la Pompa JL: Differential Notch signaling in the epicardium is required for cardiac inflow development and coronary vessel morphogenesis. Circ Res 108: 824-836, 2011.
27. Bolós V, Grego-Bessa J and de la Pompa JL: Notch signaling in development and cancer. Endocr Rev 28: 339-363, 2007.
28. Collesi C, Zentilin L, Sinagra G and Giacca M: Notch1 signaling stimulates proliferation of immature cardiomyocytes. J Cell Biol 183: 117-128, 2008.
29. Yu B and Song B: Notch 1 signalling inhibits cardiomyocyte apoptosis in ischaemic postconditioning. Heart Lung Circ 23: 152-158, 2014.
30. Gersh BJ, Sliwa K, Mayosi BM and Yusuf S: Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 31: 642-648, 2010.
31. Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ, Lips DJ and Doevendans PA: Role of apoptosis in reperfusion injury. Cardiovasc Res 61: 414-426, 2004.
32. Velazquez EJ and Bonow RO: Revascularization in severe left ventricular dysfunction. J Am Coll Cardiol 65: 615-624, 2015.
33. Yang J, Guo X, Yang J, Ding JW, Li S, Yang R, Fan ZX and Yang CJ: RP105 protects against apoptosis in ischemia/reperfusion-induced myocardial damage in rats by suppressing TLR4-mediated signaling pathways. Cell Physiol Biochem 36: 2137-2148, 2015.
34. 2-induced apoptosis in neonatal cardiomyocytes. Int J Clin Exp Pathol 8: 5491-5496, 2015.
35. Tong Z, Jiang B, Wu Y, Liu Y, Li Y, Gao M, Jiang Y, Lv Q and Xiao X: MiR-21 protected cardiomyocytes against doxorubicin-induced apoptosis by targeting BTG2. Int J Mol Sci 16: 14511-14525, 2015.
36. Boccalini G, Sassoli C, Formigli L, Bani D and Nistri S: Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: Involvement of the Notch-1 pathway. FASEB J 29: 239-249, 2015.